HD4 Pharm Flashcards

(47 cards)

0
Q

Artemether/Iumafantrine (coartem)

A

Mech: unknown
Route: oral – CYP 450 metab.
Use: for acute P. falciparum malaria (*NOT for prophylaxis or severe)
SE: hypersensitivity (urticaria & angioedema)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

Malarone

A

(combo of atovaquone & proguanil)
Mech: block pyrimidine synthesis
Route: oral; biliary & urinary excretion.
Use: to Tx malaria from P. falciparum (acute, uncomplicated)
(SE: headache, GI)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Nitazoxanide

A
Mech: interferes w/ energy production
Route: oral, hepatic metab (but NOT CYP)
Use: diarrhea from Giardia lamblia or Cryptosporidium parvum
SE: none
*NOT effective if immunocompromised
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Paromycin

A

Mech: blocks protein synthesis
Route: oral, poor absorption –> Luminal
Use: intestinal amoebiasis (NOT for systemic inf)
SE: nausea, abdominal crampls, diarrhea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Types of malaria

A
  1. Plasmodium falciparum: => malignant tertiary fever (deadly), most drug resistance.
  2. Plasmodium vivex, ovale, malariae: => benign tertiary fever, relapse common.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

three types/approaches to treatment for malaria

A
  1. clinical cure: eliminate all erythrocytic forms
  2. radical cure: eliminate all erythrocytic AND exoerythrocytic forms
  3. prophylaxis (prevention/protection)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Drugs used for superficial fungal infections (skin, gut, oral cavity, eyes)

A

*rarely life-threatening, unless immuno-compromised.
1. Nystatin
2. Griseofulvin
3. Clotrimazole
4. Terbinafine
(mostly used superficially only too toxic for systemic use)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

drugs used for systemic fungal infections

A
  1. Amphotericin B
  2. Flucytosine
  3. Fluconazole
  4. caspogungin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Terbinafine

A

Mech: inhibits ergosterol synth. fungistatic OR fungicidal
Route: topical or oral & hepatic metab.
Use: onychomycosis (on fingernails), candida, trychophyton
SE: *watch for P450 induction/inhibition, liver dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Caspofungin

A

Mech:
Route:
Use: for aspergillous (esp. invasive) or candida
SE:

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Nystatin

A

Mech: binds to ergosterol (same as ampho B)
Route: topical (to skin & mucous membranes), poor absorption
Use: candida infections (skin, bowel, etc.)
SE: —

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Clotrimazole

A

Mech: inhibit ergosterol
Route: topical (NOT oral)
Use: candidiasis
SE: —

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Prednisone

A

Mech: glucocorticoid, modulates gene expression
Use: immune-suppressant for RA, SLE, severe psoriasis, neoplasia
Route: prodrug, metab @ liver
SE: (not very selective) -> insomnia, weight gain, Cushings, susceptible to infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Sirolimus

A

Anti-proliferative immune-suppressant
Mech: binds FKB-12 -> complex inhibits mTOR, so –l T cell activation
Use: kidney rejection prophylaxis or chronic rejection
*(NOT liver or lung)
Route: metab in liver
SE: edema, HTN, risk infections & malignancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Drugs that inhibit CYP450

A
  1. Ca2+ blockers
  2. Anti-fungals (fluconazole, ketoconazole)
  3. erythromycin
  4. HIV protease inhibitors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Drugs that induce CYP450

A
  1. Rifampin

2. Phenytoin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Azathioprine

A

Anti-proliferative immune-suppressant prodrug
Mech: blocks de novo purine synthesis (active as 6-mercaptopurine)
Use: prevent kidney rejection OR refractory RA
SE: hepatotoxicity, myelosuppression, mucositis, GI Sxs, *teratogen & carcinogen!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Cyclophosphamide

A

anti-proliferative immune-suppressant, Prodrug (metab by liver)
Mech: electrophile cross-linking of DNA
Use: BMT conditioning, RA (off-label)
SE: myelosuppression, GI, bladder toxicity, ovarian failure & sterility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Methotrexate

A

anti-proliferative immune-suppressant,
Mech: –l dihydrofolate reductase, methylated: –l Thymidilate synthase
(for incorporation of dUTP into DNA)
Use: severe RA *even kids w/ juvenile RA, recalcitrant psoriasis
SE: myelosuppression, mucositis, acute renal failure

19
Q

Equine Thymocyte Immune Globulin (ETIG)

A

Mech: lymphcyte selective immune-suppressant;
Use: renal allograft rejection prophylaxis, acute rejection, induce immuno-suppression
SE: leukopenia, thrombocytopenia, transfusion rxn, risk infection or malignancy

20
Q

OKT3

A

monoclonal Ab for CD3 Ag on human T cells => reduce # circulating T cells
Use: Acute renal allograft rejection
SE: cytokine storm, anaphylactic or transfusion rxn, risk of inf or malignancy

21
Q

Misoprostol

A

Mech: PGE4 analog => anti-secretory and mucosal protectant
Use: Reduce risk of NSAID-induced gastric ulcers
PK: oral prodrug with rapid clearance
SE: Teratogenic! (Preg. category X), GI & CNS Sxs

22
Q

Dexamethasone

A

corticosteroid, *hepatic metab.
Use: anti-emetic (mech unknown), and for Ulcerative Colitis
SE: insomnia, mood changes, weight gain/Cushings, susceptible to infection

23
Q

Arepitant

A
Mech: NK1 R antagonist --l substance P
Use: anti-emetic (for chemotherapy pts)
*hepatic metabolism
SE: Contraind if liver failure, GI & CNS effects
DDIs: anti-fungals, warfarin, etc.
24
Scopolamine
Mech: muscarinic R antagonist (belladona) Route: percutaneous patch placed behind ear Use: prevent nausea & vomiting from motion sickness or post-surgical SE: Dry mouth, drowsiness Contraind: liver or kidney impairment
25
Primary induction therapy for cancer
= medication used as palliative - reduce progression of tumor - reduce tumor-related Sxs - prolong survival * not expected to cure.
26
Neoadjuvant therapy for cancer
= medication used, complimentary to surgical management | improve surgical outcome, survival, and quality of life
27
Adjuvant Therapy for cancer
medication used to prevent recurrence of cancer (local and systemic), improves overall survival. *used AFTER initial (surgical) treatment
28
Mitotane
Mech: Adrenolytic agent (selectively toxicity to adrenal cortical tissue) Use: adrenocortical cancers SE: adrenal insufficiency, nausea & vomiting
29
Tamoxifen
Mech: Selective estrogen R modulator (antagonist, competes w/ endog. estradiol) Use: adjunct to breast cancer treatment (only if ER+) SE: (Many, significant!) Menopausal Sxs, fluid retention/periph. edema, endometrial cancer... * DDI w/ other CYP450-associated drugs bc activated by CYP450!
30
Anastrazole
Mech: non-steroidal aromatase inhibitor (--l androgen to estrogen conversion) Use: Metastatic breast cancer or adjuvant Tx (if early & HR+) in POST-menopausal women SE: hot flashes, arthralgia, peripheral edema, headache, etc.
31
Tretinoin
Mech: ~unknown. Vit A analog => induces differentiation of promyelocytes to myelocytes Use: ChemoTx for Acute Promyelocytic Leukemia SE: Vit A toxicity, Retinoid acid syndrome, MI, cardiac ischemia, stroke, pulm. HTN
32
Cetuximab
Mech: anti-EGFR monoclonal Ab (blocks mitogenic & anti-apoptotic signals) Use: colorectal, head, & neck cancers SE: Infusion-related reactions (if once, will never give again)
33
Pentostatin
Mech: purine analog, Inhibits adenosine deaminase & 1 C transfers (& DNA synthesis) Use: hairy cell leukemia SE: myelosuppression
34
Erlotnib
Mech: EGFR tyrosine kinase inhibitor => growth arrest Use: lung or pancreatic cancer (non-small cell) SE: Interstitial lung disease!, GI perforation, hepatotoxicity, renal failure *CYP450 metabolism
35
Bevacizumab
Mech: Anti-VEGF monoclonal Ab Use: inhibit angiogenesis, targets HEALTHY cells! (cancer chemoTx) SE: GI bleeding, poor wound healing, pulmonary hemorrhage, arterial thrombotic events
36
Osetamavir
Mech: inhibits viral Neuraminidase *= esterified pro-drug Use: influenza (type A and B) -- prophylaxis or acute Tx if age <2 yrs SE: stevens-Johnson syndrome (rare, fatal) *not as effective as amantadine, but used more
37
Foscarnet
Mech: inhibits DNA polymerase (of HSV, CMV, others) Use: CMV retinitis, acyclovir-resistant CMV or VZV SE: renal impairment
38
Acyclovir
Mech: inhibits viral DNA polymerase, *prodrug, selectively activated by viral thymidine kinase Use: HSV & VZV (if immunocompromised), HSV encephalitis, transplant pt prophylaxis SE: WELL tolerated :)
39
Gancyclovir
Mech: inhibits DNA polymerase & suppresses chain elongation, * prodrug (phosphorylated by CMV) Use: to manage (NOT cure) CMV in immunocompromised pts Route: oral or IV, crosses BBB. renal excretion SE: toxicity limits dosing (may co-treat w/ valgancyclovir or famcyclovir)
40
AZT (aka: Zidovudine)
Mech: inhibits HIV reverse transcriptase (blocks reverse transcriptase) and inhibits chain elongation Use: Tx/control HIV infections, reduce vertical transmission, post-exposure prophylaxis SE: BM suppression/anemia, headaches, rashes, fever, diarrhea, insomnia (many ppl cannot tolerate it)
41
Nevirapine
Mech: inhibits RT (reverse transcriptase), an "NNRTI" *does NOT compete w/ nucleoside RT inhibitors ("nRTIs") Use: combo therapy of HIV-1 SE: Severe skin rxns, hepatotoxicity, DDI (bc CYP450 INDUCER) *CYP450 metab. (risk DDIs, ie: reduces HIV protease inhibitor effect)
42
Inidavir
Mech: HIV protease inhibitor (block polyprotein maturation) Use: combo Tx for HIV (1 or 2, with other anti-retrovirals) SE: --
43
Enfuvertide
Mech: inhibits fusion of viral & cellular membranes (synthetic AA, binds to gp41 subunit of HIV1) Use: HIV-1 in "treatment-experienced patients" (w/ HIV replication still) Route: subcut. injection 2x/day SE: injection site rxn, pneumonia, hypersensitivity rxns, *NO DDIs
44
Raltegravir
Mech: inhibits catalytic activity of HIV-1 integrase Use: HIV-1 in treatment-experienced pts SE: rhabdomyolysis, myopathy, (& headache, fatigue, etc.)
45
Maraviroc
Mech: CCR5 coR antagonist (reversible), blocks interaction w/ HIV1 Use: only CCR5-tropic strains of HIV1 (adults) SE: hepatoxicity & rash, allergic rxn *CYP450 metab
46
Why viral infections are hard to treat
1. viruses = intracellular parasites, use host cell machinery to replicate 2. replication starts before Sxs occur 3. broad-selectivity not possible for anti-virals